Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -200.6% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 3.6 | n/a |
Pr/Book | 1.7 |
Latest | F'cast | |
---|---|---|
Revenue | 90.3% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1.70 | (3.51) | (17.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.16 | (6.95) | (27.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 2.40 | (10.54) | (32.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 4.57 | (8.90) | (28.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Collaboration with global pharmaceutical partner | 26-Mar-2025 | 07:00 | RNS |
Arecor partnership with biopharmaceutical company | 12-Mar-2025 | 07:00 | RNS |
Arecor Full Year 2024 Trading Update | 03-Feb-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 43.91p |
Change Today | 0.41p |
% Change | 0.94 % |
52 Week High | 160.00 |
52 Week Low | 42.00 |
Volume | 83,563 |
Shares Issued | 37.76m |
Market Cap | £16.58m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
12:54 | 481 @ 42.30p |
11:19 | 646 @ 42.30p |
09:36 | 25,000 @ 42.00p |
09:25 | 22,977 @ 43.50p |
09:24 | 22,977 @ 43.50p |
CEO | Sarah Jennifer Howell |
CFO | David Ellam |
You are here: research